DrugPatentWatch Database Preview
Taro Pharm Inds Ltd Company Profile
» See Plans and Pricing
What is the competitive landscape for TARO PHARM INDS LTD, and when can generic versions of TARO PHARM INDS LTD drugs launch?
TARO PHARM INDS LTD has twenty-four approved drugs.
There are two US patents protecting TARO PHARM INDS LTD drugs. There are two tentative approvals on TARO PHARM INDS LTD drugs.
There are ten patent family members on TARO PHARM INDS LTD drugs in seven countries and nineteen supplementary protection certificates in eleven countries.
Summary for Taro Pharm Inds Ltd
| International Patents: | 10 |
| US Patents: | 2 |
| Tradenames: | 16 |
| Ingredients: | 14 |
| NDAs: | 24 |
Drugs and US Patents for Taro Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharm Inds Ltd | DESLORATADINE | desloratadine | SOLUTION;ORAL | 202592-001 | Jun 30, 2015 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Taro Pharm Inds Ltd | ILOPERIDONE | iloperidone | TABLET;ORAL | 207098-003 | Jul 22, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Taro Pharm Inds Ltd | DEFERIPRONE | deferiprone | TABLET;ORAL | 208800-001 | Feb 8, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Taro Pharm Inds Ltd | ILOPERIDONE | iloperidone | TABLET;ORAL | 207098-004 | Jul 22, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Taro Pharm Inds Ltd | TOPICORT | desoximetasone | OINTMENT;TOPICAL | 018594-001 | Jan 17, 1985 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Taro Pharm Inds Ltd | ILOPERIDONE | iloperidone | TABLET;ORAL | 207098-007 | Jul 22, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Taro Pharm Inds Ltd | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | CREAM;TOPICAL | 040039-001 | Nov 26, 1997 | AT | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for TARO PHARM INDS LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
International Patents for Taro Pharm Inds Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2013032405 | Start Trial |
| China | 103087095 | Start Trial |
| China | 101287374 | Start Trial |
| Japan | 2009500422 | Start Trial |
| Brazil | PI0612686 | Start Trial |
| Israel | 188512 | Start Trial |
| Japan | 5474347 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Pharm Inds Ltd Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1304992 | C01304992/01 | Switzerland | Start Trial | PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014 |
| 1304992 | SPC/GB13/061 | United Kingdom | Start Trial | PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624 |
| 1304992 | CR 2013 00053 | Denmark | Start Trial | PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322 |
| 0809498 | 10C0038 | France | Start Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| 0152897 | SPC/GB01/012 | United Kingdom | Start Trial | PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115 |
| 0663828 | C300085 | Netherlands | Start Trial | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| 1586316 | C 2011 004 | Romania | Start Trial | PRODUCT NAME: BROMFENAC, SARURILE SI HIDRATII SAI ACCEPTABILI FARMACEUTICACID 2-[2-AMINO-3-(4-BROMOBENZOIL)FENILACETIC; NATIONAL AUTHORISATION NUMBER: RO EU/1/11/692/001; DATE OF NATIONAL AUTHORISATION: 20110518; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EMEA EU/1/11/692/001; DATE OF FIRST AUTHORISATION IN EEA: 20110518 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
